Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudomonas species surface receptors represent a broad category of proteins and molecules located on the outer membrane of bacteria within the Pseudomonas genus, most notably the opportunistic pathogen Pseudomonas aeruginosa. These receptors, which include outer membrane porins like OprD, siderophore receptors such as FpvA, and surface lectins like LecA, are essential for the bacterium's survival, nutrient acquisition, and environmental adaptation [1][2]. In clinical settings, these surface structures play a pivotal role in pathogenesis by facilitating adherence to host tissues and the formation of resilient biofilms, which are particularly problematic in patients with cystic fibrosis or compromised immune systems [3][4]. From a therapeutic perspective, these receptors are highly significant as they serve as the primary entry points or targets for several classes of antibiotics and experimental biologics. For instance, the antibiotic cefiderocol exploits siderophore receptors to bypass traditional resistance mechanisms, while monoclonal antibodies like MEDI3902 are designed to bind surface antigens to prevent host cell damage and enhance bacterial clearance [5][6]. However, the therapeutic utility of targeting these receptors is often challenged by the bacterium's ability to rapidly mutate or downregulate these proteins, leading to high levels of intrinsic and acquired resistance [7].
Siderophore-mediated active transport (Trojan horse mechanism), Disruption of outer membrane integrity via lipopolysaccharide binding, Neutralization of surface-exposed virulence factors, Inhibition of bacterial adhesion to host cells
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas species surface receptors.